News | November 17, 2025
AstraZeneca and Sun Pharma partner to expand hyperkalemia treatment in India
Both companies will promote, market and distribute Sodium Zirconium Cyclosilicate in India under different brand names
Both companies will promote, market and distribute Sodium Zirconium Cyclosilicate in India under different brand names
FDA closes inspection at Zydus' oncology injectable manufacturing facility in SEZ1, Ahmedabad with 2 observations
EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025
Total income for the period stood at Rs. 7101.28 crore
ALBIS will present a selection of advanced materials from its broad healthcare portfolio
The new formulation features what Abbott calls a “triple care system,” anchored by a blend of nutrients aimed at supporting blood sugar control and metabolic health
Leuprolide Acetate injection is indicated in the palliative treatment of advanced prostatic cancer
The observations are procedural in nature and will be responded to within the stipulated time
Novartis is the only pharmaceutical company with a dedicated commercial RLT portfolio
Acquisition brings highly differentiated clinical-stage obesity candidates with potential to reshape the treatment landscape
Subscribe To Our Newsletter & Stay Updated
